Tempus AI's 10% dip reveals an opportunity as Q2 estimates are poised to exceed expectations, fueled by strong deals and ...

Tempus AI offers a strong business model with AI-driven genomic data, resilient demand, and significant growth prospects.

Patient Capital Management, a value investing firm, released its “Patient Capital Opportunity Equity Strategy” second-quarter ...

Tempus AI, Inc. (NASDAQ:TEM) is one of the stocks on Jim Cramer’s radar. Answering a caller’s query about the company during the lightning round, Cramer said: “Okay, another company that’s just losing ...

Tempus AI is a growth stock that is down 31% from all-time highs. Here's why TEM AI stock could be a part of your TFSA portfolio right now.

AI Stocks are leading the next wave of tech innovation, from chipmakers to healthcare and voice tech.SoundHound stock has gained over 125% in 202 ...

TEM stock rallies 7.3% after the FDA clears its second cardiology AI tool, witnessing a 48% surge in just three months.

Tempus AI and NVIDIA are both actively working at the intersection of AI and healthcare. Tempus AI, while advancing precision ...

Former House Speaker Nancy Pelosi said back in 2022 the Senate would soon vote on a bill banning members of Congress from trading individual stocks. Roughly three years later, Pelosi is no ...

Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting ...